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51 ABSTRACT 
 
52 Background: CD14, a co-receptor for several pattern recognition receptors and a 
 
53 widely used monocyte/macrophage marker, plays a key role in host responses to 
 
54 Gram-negative  bacteria.  Despite  its  central  role  in  the  inflammatory  response  to 
 
55 lipopolysaccharide and other microbial products, and in dissemination of bacteria in 
 
56 some  infections,  the  signaling  networks  controlled  by  CD14  during  urinary  tract 
 
57 infection (UTI) are unknown. 
  
58 Methods: We used uropathogenic  Escherichia coli (UPEC) infection of  wild-type 
 
59 (WT) C57BL/6 and Cd14-deficient mice and RNA-sequencing (RNA-seq) to define the 
 
60 CD14-dependent transcriptional signature, and role of CD14, in host defense against 
 
61 UTI in the bladder. 
  
62 Results: UPEC-induced the up-regulation of Cd14 and monocyte/macrophage related 
 
63 genes Emr1/F4/80 and Csf1r/c-fms, which was associated with lower UPEC burdens 
 
64 in WT compared to Cd14-deficient mice. Exacerbation of infection in Cd14-deficient 
 
65 mice was associated with the absence of a 491-gene transcriptional signature in the 
 
66 bladder that encompassed multiple host networks not previously associated with this 
 
67 receptor.  CD14-dependent pathways  included  immune  cell  trafficking,  differential 
 
68 cytokine production in macrophages, and IL-17 signaling. Depletion of 
 
69 monocytes/macrophages in the bladder by administration of liposomal clodronate led 
 
70 to higher UPEC burdens. 
  
71 Conclusion: This study identifies new host protective and signaling roles for Cd14 in 
 
72 the bladder during UPEC UTI. 
  
73 Keywords: urinary tract infection; uropathogenic Escherichia coli; host response 
74 INTRODUCTION 
 
75 Uropathogenic Escherichia coli (UPEC) is the main causative agent of urinary tract 
 
76 infections (UTIs), which represent some of the most common bacterial diseases in 
 
77 humans  [1].  Acute  infection  typically  presents  as  cystitis,  but  can  progress  to 
 
78 pyelonephritis. UPEC can also cause urosepsis, the severity of which depends mostly 
 
79 upon the host response [2]. UPEC express multiple adhesins and virulence factors 
 
80 that provoke  inflammation and  enable  bacterial  colonization  of  the bladder  [3-5]. 
 
81 UPEC can also suppress the innate immune response via expression of specific 
 
82 virulence-associated proteins including TcpC [6-9].  
83 
 
84 Early stages of UTI pathogenesis are not well described; however, recent descriptions 
 
85 of two whole bladder transcriptomes have provided insight into genome-wide early host 
 
86 responses to UPEC [10, 11]. Key biological pathways that are induced by UPEC 
 
87 include the synthesis of several interleukins (IL) and chemokines [10-13]. Important 
 
88 roles for tumor necrosis factor, nitric oxide [14], CXC chemokine receptor 2 [15], 
 
89 Tamm-Horsfall protein (uromodulin) [16, 17], IL-17A [18], and CD44 [19] in the control 
 
90 of infection have been described using murine UTI models [20]. CXCL2 (macrophage 
 
91 inflammatory protein 2 [MIP-2]) forms part of early host defense [6], as does IL-10 
 
92 [10]. A rapid influx of neutrophils into the bladder coincides with IL-8 and G-CSF 
 
93 release, which aids in controlling infection [21]. UPEC also induces apoptosis in host 
 
94 cells that may contribute to eradication of bacteria from the bladder [22]. Certain 
 
95 UPEC adhesins including type 1 and P fimbriae trigger some of these processes [5]. 
 
96 
 
97 There is emerging evidence  that macrophages  may play a role  in host  defense 
 
98 against UPEC. Neutralization of G-CSF, a neutrophil mobilizing cytokine, led to a 
99 decrease  in  bacterial  loads  in  the  bladder  of  mice,  coincident  with  increased 
 
100  production  of  macrophage-activating  cytokines  including  IL-1β  and  MCP-1  [21]. 
 
101  Myeloid-restricted  genes  including  Emr1/F4/80  and  Cd14  were  found  to  be  up- 
 
102  regulated in the bladder within hours of infection [10, 23] and macrophages infiltrate 
 
103  the bladder of mice with UTI as early as 14 h post-infection (p.i.) [21, 24]. UPEC were 
 
 
104  also shown to localize in Lamp1+ vesicles during intracellular survival in macrophages 
 
105  [23], and undergo transcriptional remodeling in this environment to permit 
 
106  intramacrophage survival [25]. A role for macrophages in UTI is likely because the 
 
107  number of these cells increases, probably due to chemokine responses, during UTI 
 
108 
 
109 
[21, 26]. 
 
110  CD14 is a GPI-anchored co-receptor used by several pattern-recognition receptors, 
 
111  most notably TLR4, in the recognition of LPS [27, 28]. Soluble secreted forms can 
 
112  also increase the sensitivity of non-CD14 expressing cells to LPS [29]. Consequently, 
 
113  CD14-deficient mice experience a muted inflammatory response including reduced 
 
114  production of pro-inflammatory cytokines. In one study, CD14-deficient mice developed 
 
115  more severe bacteremia but better control of tissue infection (e.g. lungs, spleen, bone 
 
116  marrow) following infection with E. coli 0111:B4 compared to WT mice [30]. The LPS 
 
117  receptor  complex,  which  includes  CD14, MD-2  and  TLR4,  is  utilised  by  bladder 
 
118  epithelial cells to enable the activation of NF-κB and p38 MAPK in response to UPEC 
 
119  [31]. However, the role of CD14 in innate immune signaling and defense against UTI 
 
120  has not been explored. Here, we have defined the extent of CD14 signaling in the 
 
121  bladder and its role in early anti-bacterial defense against UPEC UTI. 
122  METHODS 
 
123  Murine UTI model – We used female C57BL/6 mice (8-10 wks; Jackson Laboratories 
 
124  [Bar Harbor, Maine], and Animal Resources Centre [Canning Vale, WA]) inoculated 
 
125  using a transurethral method [20], with minor modifications. CD14-deficient B6.129S- 
 
 
126  Cd14tm1Frm/J mice (003726) were purchased with controls (000664) from Jackson 
 
 
127  Laboratories. Mice were infected with 109  CFU of UPEC CFT073 (O6:H1:K2), or 
 
128  mCherry fluorescent protein-tagged UPEC CFT073, in 40 µl PBS. Urine was collected 
 
129  at 2 h, 24 h, and 5 d for colony counts. Tissues were used for counts, RNA isolation, 
 
130  flow  cytometry  or  immunohistochemistry  (IHC).  Macrophages  were  depleted  by 
 
131  intraperitoneal (i.p.) administration of 200 µL of commercial clodronate liposomes 
 
132  (www.clodronateliposomes.com)  24  h  and 2  h  prior  to  infection.  This  study  was 
 
133  performed in accordance with the guidelines of the NHMRC (Australia). The Institutional 
 
134  Animal Care and Use Committee of University of Alabama at Birmingham (UAB), and 
 
135  Griffith University Animal Ethics Committee approved this study (Approval number: 
 
136 
 
137 
UAB: 080708186, Griffith: MSC/14/08AEC). 
 
138  RNA isolation and qRT-PCR – Total RNA was isolated from bladders using Trizol 
 
139  (Gibco, Mulgrave, VIC, Australia) and was used to generate cDNA as previously 
 
140  described  [10,  11].  qRT-PCR  was  carried  out  using  a  GeneAmp  7700  System 
 
141  (Applied Biosystems) as previously described [32]. Primer sequences are described 
 
142  elsewhere  [10,  11,  23,  32].  Relative  expression  was  determined  by  normalizing 
 
 
143  reaction CTs to the reference -actin. ∆CT values were used in the formula 2-[∆∆Ct] to 
 
144 
 
145 
calculate relative mRNA expression levels of target genes. 
146  RNA-Seq of CD14-dependent innate immune responses to UPEC – We performed 
 
 
147  next-generation mRNA-sequencing in WT C57BL/6 and B6.129S-Cd14tm1Frm/J mice 
 
148  to define CD14-dependent, UPEC-regulated gene expression in the bladder. We used 
 
149  the Illumina HiSeq2500 and the latest versions of sequencing reagents and flow cells 
 
150  that provide up to 300Gb of sequence information per cell. Briefly, mice were infected 
 
151  or received PBS and RNA was isolated as above at 8 h p.i. Total RNA was subjected 
 
152  to two rounds of poly A+ selection and converted to cDNA. We used TruSeq library 
 
153  generation kits, as  per  the manufacturer’s  instructions  (Illumina, San Diego,  CA, 
 
154  USA). Library construction consisted of random fragmentation of the polyA mRNA, 
 
155  followed by cDNA production using random primers. The ends of the cDNA were 
 
156  repaired, A-tailed and adaptors ligated for indexing (up to twelve different barcodes 
 
157  per lane) during the sequencing runs. The cDNA libraries were quantitated using 
 
158  qPCR in a Roche LightCycler 480 with the Kapa Biosystems kit for library quantitation 
 
159  (Kapa Biosystems, Woburn, MA), prior to cluster generation. Clusters were generated 
 
 
160  to  yield  approximately  725K-825K  clusters/mm2.  Cluster  density  and  quality  was 
 
161  determined during the run after the first base addition parameters were assessed. We 
 
162  ran  paired  end  2x50bp  sequencing  runs  to  align  the  cDNA  sequences  to  the 
 
163 
 
164 
reference genome. 
 
165  For data pre-processing and bioinformatics analysis, TopHat version 2.0.11 was used 
 
166  to align the raw RNA-Seq fastq reads to the mouse reference genome version 10 
 
167  from the UCSC genome browser gateway (http://genome.ucsc.edu/cgi- 
 
168  bin/hgGateway?db=mm10) using the short read aligner Bowtie version 2.1.0 [33-35]. 
 
169  TopHat was also used to analyse the mapping results to identify splice junctions 
 
170  between  exons.  Cufflinks  version  2.1.1  used  the  aligned  reads  from  TopHat  to 
171  assemble transcripts, determine their abundance and test for differential expression 
 
172  and regulation [35, 36]. Cuffmerge, which is part of Cufflinks, merged the assembled 
 
173  transcripts to a reference annotation and tracked Cufflinks transcripts across multiple 
 
174  experiments. Finally, Cuffdiff was used to identify significant changes in transcript 
 
175  expression,  splicing  and  promoter  use.  Genes  that  met  certain  criteria  (i.e.  fold 
 
176  change ≥ ±2.0, q-value < 0.05, default Cuffdiff FDR < 0.05) were further analysed 
 
177  using Ingenuity’s Pathway Analysis (IPA) tool (www.ingenuity.com) and innatedb’s 
 
178  Overrepresentation Analysis (ORA) tool (www.innatedb.com). Raw and processed 
 
179 
 
180 
data are deposited in Gene Expression Omnibus (accession GSE68220). 
 
181  Flow cytometry – For ex vivo bladder analyses, whole tissues were removed at 2 h, 
 
182  24 h and 5 d p.i. Tissues were cut into small (approx. 1 mm 1 mm) fragments and 
 
 
183  digested using 1 mg mL-1  collagenase A (Roche, Castle Hill, NSW, Australia) and 
 
184  0.057KU DNase I (Sigma-Aldrich, Castle Hill, NSW, Australia), in RPMI containing 
 
185  20mM  HEPES  (Invitrogen,  Mulgrave,  VIC,  Australia)  and  10%  FBS  (Moregate 
 
186  Biotech, Bulimba, QLD, Australia). Tissues were incubated at 37°C, shaking at 750 
 
187  rpm (Eppendorf Thermostat) for 1 h; at 25 min into the incubation, samples were 
 
188  passed  through  a  19G  syringe  to  enhance  digestion.  To  obtain  single  cell 
 
189  suspensions, samples were passed through a 45 µm cell strainer (BD Biosciences) 
 
190  into a well of a 6 well plate. Samples were centrifuged at 500 g for 5 min and cells 
 
191  were washed with wash buffer (1% FBS in PBS) and centrifuged again. Cells were 
 
192  resuspended in blocking buffer (2% BSA for 1 h, room temperature [22°C]) and 
 
193  incubated for 1 h, room temperature. Fc receptors were blocked using 1% mouse 
 
194  serum  in  wash  buffer  for  1  h,  room  temperature.  Cells  were  centrifuged  and 
 
195  resuspended in 200 µL wash buffer; cell counts were performed, and cells were 
196  placed in flow cytometry tubes at 106  cells per tube and stained with anti-mouse 
 
197  F4/80 APC conjugated (eBiosciences) and anti-mouse CD14 primary antibody (Santa 
 
198  Cruz, Dallas, TX, USA), followed by a secondary anti-goat-PE (BD Biosciences) for 
 
199  30 min each, in the dark (antibodies were used at the concentrations recommended 
 
200  by the manufacturers). Cells were washed, resuspended in 4% paraformaldehyde, 
 
201  and analysed the following day using a LSRII Fortessa flow cytometer (BD Bioscience, 
 
202 
 
203 
North Ryde, NSW, Australia). Data were analysed using FACSDiva v6 software. 
 
204  Immunohistochemistry and confocal microscopy – Whole bladders were placed 
 
205  in optimal cutting temperature media, frozen in liquid nitrogen, and cryosections (4 
 
206  µm) were cut. For F4/80 staining, sections were formalin-fixed and antigen retrieval 
 
207  was performed using proteinase K. Tissues were blocked and primary F4/80 antibody 
 
 
208  was used at 10 µg mL-1 (Abcam, Melbourne, VIC, Australia), followed by anti-rat-FITC 
 
209  secondary antibody (1/400 dilution; Sigma-Aldrich). For CD14 staining, sections were 
 
210  fixed with cold acetone for 20 min, followed by blocking of endogenous peroxidases 
 
211  with 0.3% hydrogen peroxidase in methanol for 30 min. Tissues were blocked and 
 
212  sections were incubated with primary antibody for 2 h at room temperature (1/100; 
 
213  Santa Cruz, Dallas, TX, USA), followed by FITC secondary antibody (1/400 dilution, 
 
214  Sigma-Aldrich).  Sections  were  viewed  using  an  Olympus  Fluoview  FV1000-IX81 
 
215 
 
216 
microscope and images were captured using FV10-ASW 4.0 viewer. 
 
217  Statistical analysis – Data were compared using a Mann Whitney U-test or Two-way 
 
218  ANOVA and a Bonferroni’s post-test where specified. Analyses were performed using 
 
219  GraphPad Prism version 5 with a level of significance of p < 0.05. 
220  RESULTS 
 
221  Cd14 expression during acute murine UPEC UTI 
 
222  Microarray analysis of UPEC-infected mouse bladders showed macrophage signature 
 
223  genes and myeloid leukocyte activation in the innate response to infection [10, 11]. We 
 
224  used innateDB [37] and IPA to further explore UPEC-regulated gene expression, and 
 
225  identified Cd14 as among the most highly regulated genes, along with others related 
 
226  to macrophage activity, including Ccl3 (MIP-1α), TLR2, TLR6, Cd80 and Cd86 (Fig. 
 
227  1A). We used qRT-PCR to further analyse the expression of macrophage signature 
 
228  genes, including Cd14, Emr1/F4/80 and Csf1r/c-fms over a time course and found that 
 
229  Cd14 expression was significantly elevated between 2 h, 8 h and 24 h p.i., with a peak 
 
230  of expression at 8 h p.i. (Fig. 1B); Csf1r/c-fms was significantly elevated at both 2 h 
 
231  and 24 h p.i., and Emr1/Fb4/80 was also significantly elevated at both 2 h and 24 h p.i. 
 
232  We next examined the function of CD14 in control of UPEC UTI, including its role in 
 
233  global transcriptional responses that stem from infection and as a biomarker of bladder 
 
234 
 
235 
monocyte/macrophage activity during UTI. 
 
236  CD14 contributes to the control of acute UPEC UTI in mice 
 
 
237  Infection of WT C57BL/6 and CD14-deficient B6.129S-Cd14tm1Frm/J mice revealed that 
 
238  CD14-deficient mice exhibited significantly higher (P=0.0281) bacterial burdens in the 
 
 
239  bladder compared to WT mice with means of 3.6 x 105 CFU vs 5.8 104 CFU at 24 h 
 
240  p.i., respectively (Fig. 2A; P=0.0307). The difference in urine counts between these 
 
241  mice was not statistically significant (Fig. 2B; P=0.0552). There was no significant 
 
242  difference in the recovery of UPEC from kidneys of WT and CD14-deficient mice (Fig. 
 
243  2C). In separate time course experiments, we observed significantly higher recovery 
 
244  of UPEC from urines collected from CD14-deficient mice compared to WT mice at 24 
245  h p.i. (Fig. 2D; P=0.039) and 48 h p.i. (Fig. 2D; P=0.048); however, the difference at 8 
 
246  h p.i. was not significant (Fig. 2D; P=0.187). Thus, early CD14 expression in vivo 
 
247  contributes to the control of UTI by significantly restricting UPEC loads in the bladder 
 
248  and urine following acute infection; however, these significant antibacterial effects are 
 
249 
 
250 
most apparent at times following the peak of CD14 transcriptional expression (8 h p.i.). 
 
251  CD14-dependent signaling in the bladder triggered by UPEC 
 
252  RNA-Seq of infected and non-infected WT and CD14-deficient mice (at 8 h p.i., 
 
253  representing a peak of early CD14 expression) revealed 6632 genes with significantly 
 
254  altered expression in WT infected vs WT PBS control mice (Fig. 3A). Up-regulated 
 
255  genes included Cd14 (29.66-fold), IL-1(143.6-fold), IL-1 (86.3-fold), IL-10 (3.8- 
 
256  fold), IL-10ra (3.8-fold), IL-6 (32.4-fold), TNF- (15.1-fold), CCL2 (11.4-fold), Cxcl-5 
 
257  (63.1-fold) and Cxcl-9 (4.6-fold). Translational analysis of bladder tissue homogenates 
 
258  showed similar responses for many of these innate immune factors at the protein level 
 
259  (Supplementary Table S1). We also identified 2971 genes with significantly altered 
 
260  expression in CD14-deficient mice that were infected with UPEC vs CD14-deficient 
 
261  mice that received PBS; representing 55% fewer altered genes in infected CD14- 
 
262  deficient compared to WT mice (Fig. 3A). The complete gene lists are provided in 
 
263 
 
264 
 
265 
Supplementary Table S1. 
    
The gene lists identified by comparing host background (WT vs Cd14-/-) within a 
 
266  treatment (infection or PBS) are summarised in Fig. 3B. We identified 513 genes that 
 
267  were differentially regulated between UPEC-infected WT and Cd14-deficient mice, and 
 
268  407 genes in the equivalent PBS comparison (Fig. 3B). Only 50 genes were common 
 
269  among these two lists; 28 of these were expressed in the opposite direction in infected 
270  vs control mice (i.e. up-regulated or down-regulated), or exhibited a dramatically 
 
271  different level of expression between treatments. Thus, this delineates a unique UPEC- 
 
272  induced CD14-dependent transcriptional signature comprising 491 unique genes and 
 
273  responses (Supplementary Table S1 C-D); genes that were highly dependent on 
 
274  CD14 for expression (infected WT vs infected Cd14-deficient) include Myh4 (61.5- 
 
275  fold), mt-Ta,mt-Tc,mt-Tn,mt-Ty (48.7-fold), Xirp1, Sprr2d, Vwa3a, Ngp, Sntg1, Slc6a4, 
 
276  Il-17c, Chst4, and Csf2 (undefined fold-changes between 6.1 and 5.2). Genes that 
 
277  were strongly repressed by CD14 include: Ccnb1ip1 (infinity), Mir1934 (-79.5-fold), 
 
278 
 
279 
Fmo5, Krt4, Prss35, Adh7, (fold changes between -4.2 and -3.9) 
 
280  The most highly activated canonical pathways in UPEC-infected WT mice compared 
 
281  to PBS controls, as identified by IPA analysis, were cell diapedesis, macrophage 
 
282  activation and IL-10 signaling. The top Cd14-dependent canonical pathways were cell 
 
283  adhesion and diapedesis pathways, and pathways relating to IL-17. The top canonical 
 
284  pathways, biological functions and upstream mediators that define the UPEC-induced 
 
285  CD14-dependent transcriptional signature are summarised in Fig. 3C. Supplementary 
 
286  Fig. S1 shows each significant canonical pathway and the top four gene networks of 
 
287  over-expressed genes in the UPEC-induced, CD14-dependent transcriptional 
 
288  responses,  as  defined  using  IPA.  InnateDB,  used  to  identify  overrepresented 
 
289  pathways among those activated by UPEC via CD14-dependent and -independent 
 
290  mechanisms, identified many pathways that were equivalent to those identified by IPA 
 
291  such as immune-related and inflammatory pathways, and IFN signaling (Fig. 3C; and 
 
292  data not shown). All IPA and ORA-defined pathways are listed in Supplementary 
 
293 
 
294 
Table S1 E-F. 
295  Infiltrating macrophages contribute to the control of UPEC in the bladder 
 
 
296  Given that CD14 marks monocytes/macrophages, we examined macrophage (F4/80+, 
 
 
297  CD14+/F4/80+) in the bladders of mice using flow cytometry at 2 h, 24 h and 5 d p.i. as 
 
 
298  a measure of myeloid cell infiltration. There were 12-15% F4/80+ resident 
 
299  macrophages in the bladders of control mice (Fig. 4A), which increased to 20% at 2 h 
 
300  p.i. By 24 h, the numbers significantly increased further to 28% (P<0.0001) and 
 
 
301  remained elevated at 5 d p.i. (20% vs 12% F4/80+  cells in infected mice vs PBS 
 
 
302  controls,  P<0.01).  The  percentage  of  F4/80+   cells  expressing  CD14  was  also 
 
303  examined. There was no difference between UPEC and sham-infected animals at 2 h 
 
304  p.i.,  with  few  double  positive  cells  detected;  however  at  24  h  p.i.,  there  were 
 
 
305  significantly  more  F4/80+/CD14+   dual  positive  cells  in  infected  mice  vs  controls 
 
306  (P<0.05; Fig. 4A). By 5 d p.i., the percentage of dual positive cells did not differ 
 
 
307  significantly  from  control  levels.  Thus,  UPEC  causes  an  increase  in  F4/80+   and 
 
 
308  F4/80+/CD14+ cells indicating a CD14-positive macrophage response in the bladder at 
 
309 
 
310 
the early stage of acute UTI. 
 
311  Analysis of the role of macrophages in clearance of UPEC from the bladder showed 
 
 
312  that  clodronate  treatment  significantly  depleted  F4/80+   cells  in the  bladder  (30% 
 
313  decrease, P<0.01) and spleen (50% decrease, P<0.0001) when assessed at 24 h p.i. 
 
 
314  (Fig. 4B). IHC at 24 h and 5 d p.i. confirmed the depletion of F4/80+ and CD14+ cells 
 
315  (Fig. 4C and 4D; 5 d shown). Mice that received clodronate had more UPEC at all the 
 
316  time points examined with a significant difference at 24 h p.i., compared to controls 
 
 
317  (4.1 106  vs 1.06 107  CFU/0.1mg tissue; P=0.0409; Fig. 5A-C). Urine culture 
 
318  showed no significant difference between control and treated mice at 2 h or 24 h p.i., 
 
319  but mice that were depleted of macrophages had 20-fold higher UPEC counts at 5 d 
 
320  p.i.  (2.4  106   vs  4.68  107   CFU  mL-1;  P=0.0402;  Fig.  5D-F).  Thus,  chemical 
 
321  depletion of macrophages using clodronate causes a significant increase in UPEC 
 
322  colonization of the bladder. 
323  DISCUSSION 
 
324  CD14 aids in the control of infection at mucosal sites. For example, higher bacterial 
 
325  burdens  were  reported  in  the  lungs  of  CD14-deficient  mice  infected  with  the 
 
326  opportunistic  bacterial  pathogen  Acinetobacter  baumannii  [38];  CD14-neutralised 
 
327  rabbits developed E. coli pneumonia [39], and intestinal infection with Shigella was 
 
328  exacerbated following anti-CD14 treatment in  rabbits [40]. Previous studies have 
 
329  defined  the  role  of  CD14  in  TLR  signaling  [27]  and  in  macrophages  in  the 
 
330  uroepithelium [41]. In this study, we show that i) Cd14 and Emr1/F4/80 mRNA levels 
 
331  are rapidly upregulated in the bladder in response to UPEC, ii) CD14 drives a diverse 
 
332  network of host signaling pathways in response to UPEC that contribute to the early 
 
 
333  control  of  UTI,  and  iii)  an  early  bladder  cell  infiltrate  comprises  F4/80+   and 
 
 
334  F4/80+/CD14+   cells  in  response  to  UPEC  and  chemical  depletion  of  these  cells 
 
335  renders mice more susceptible to UPEC UTI. Together, these data posit CD14 as a 
 
336  master regulator of host defense and effective early control of UPEC UTI. More 
 
337  generally,  these  observations  underscore  the  broader  importance  of  CD14  for 
 
338 
 
339 
clearance of mucosal Gram-negative pathogens. 
 
340  The identification of a group of strongly activated genes in the bladder following UPEC 
 
341  infection via a CD14-dependent signaling mechanism is of particular interest; most of 
 
342  the differentially transcribed genes uncovered in our analysis are not encompassed 
 
343  within the known range of downstream signaling effects currently defined as being 
 
344  associated with CD14 [42]. For example, MYH4 and Mylpf (myosin activity), Mt-Tn 
 
345  (tRNAs  and  protein  synthesis)  and  Gm3893  (unknown  function).  Other  CD14- 
 
346  dependent genes such as CCL5 (RANTES) and Ngp (neutrophilic granule protein) 
 
347  might have been more anticipated with respect to host-pathogen interactions, but 
348  again, these have not previously been functionally associated with CD14. Our findings 
 
349  of activated canonical pathways, such as IL-10 signaling, are consistent with prior 
 
350  microarray studies in murine UPEC UTI [10, 11]. The gene expression findings in our 
 
351  pair-wise comparison of WT infected mice and WT control mice (received PBS) are 
 
352  consistent with a prior study [10] in terms of the most activated genes and canonical 
 
353 
 
354 
pathways. 
 
355  The extent of CD14 engagement of UPEC in the uroepithelium remains unknown. 
 
356  However, it is useful to note that CD14 is generally not expressed by epithelial cells to 
 
357  minimize immune responses against commensal microbes [43-45]. T24 uroepithelial 
 
358  cells do not express CD14, for example, but are LPS responsive [43]. This occurs via 
 
359  TLR4 signaling and soluble CD14 (sCD14). Biopsies of human urinary tract have 
 
360  revealed there is no epithelial expression of CD14 but there is expression on myeloid 
 
361  cells in the sub-epithelial compartment [45-47]. It is therefore likely that the extent of 
 
362  CD14-UPEC engagement in the bladder comprises a notable myeloid cell population, 
 
363  both local and infiltrating cells, which aid in the control of UPEC. Cd14-/- macrophages 
 
364  retain phagocytic capacity for E. coli and dose-dependent cytokine responsiveness in 
 
365  the context of  whole bacteria despite being  hyporesponsive to LPS [48]. Type I 
 
366  fimbriae may deliver LPS to Cd14-/-  cells to trigger a TLR4 response, leading to 
 
367 
 
368 
cytokine responses [44]. 
 
 
369  Our finding of a peak of infiltrating F4/80+ cells at 24 h p.i. in the bladder is consistent 
 
 
370  with a prior report of significant F4/80+  cell infiltration at 16 h p.i. [26]. Clodronate 
 
371  liposomes  have  been  used  to  deplete  macrophages  in  vivo  in  various  models 
 
372  including  those  of  lung  and  genital  tract  infections  [49,  50].  In  our  model,  the 
373  liposomes were delivered i.p. 24 h and 2 h prior to infection, which depleted 50% of 
 
374  macrophages systemically and 30% locally. This approach highlighted the 
 
375  requirement for macrophages in clearance of UPEC from the bladder at 24 h p.i., and 
 
376  is consistent with a previous study that demonstrated host-protective functions for 
 
377  macrophages in murine UTI [41]. Similar effects were reported in another infection 
 
378  model, where macrophage depletion in A. baumannii-infected mice had no effect 
 
379  towards bacterial loads in the lung early post-challenge (4 h), but a significant effect 
 
380  after 24 h [50]. Cd14-deficient and WT mice infected with A. baumannii also exhibited 
 
381  differential bacterial clearance in the lung but equivalent cytokine responses [38]. 
 
382  These findings of CD14- and macrophage-dependence in A. baumannii control are 
 
383 
 
384 
consistent with the current findings in the murine UTI model. 
 
385  In summary, this study defines a new host-protective role for CD14 in the bladder in 
 
386  response to UPEC infection, and delineates the first CD14-dependent transcriptional 
 
387  signature that is triggered by an infectious disease. These findings will enable future 
 
388  analysis of the signaling mechanisms that underpin CD14 function during infection and 
 
389  the potential to target or manipulate these mechanisms to resolve infection. 
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528  Figure 1: UPEC-regulated transcriptional changes in Cd14 and related genes in 
 
529  the bladder in murine UTI. (A) Systems-wide bioinformatic analysis using innateDB 
 
530  shows the over representation of Cd14 and TLR-encoding genes (up-regulated in 
 
531  pink; no change in expression in green) in the bladder transcriptional response to 
 
 
532  infection in female C57BL/6 mice at 2 h after transurethral challenge with 109  CFU 
 
533  UPEC  CFT073 [10].  Fold  changes  in  gene  expression,  relative  to  non-infected 
 
534  controls, are shown as numbered. Raw array data were previously deposited (record 
 
535  GSE26509)  in  the  Gene  Expression  Omnibus.  (B)  qRT-PCR  analysis  of  Cd14, 
 
536  Emr1/F4/80 and Csf1r/c-fms gene expression between 2 h and 24 h p.i. demonstrates 
 
537  a peak of early Cd14 gene expression at 8 h p.i. Data represent fold changes ± SEM 
 
538  for 5 mice; assays were performed in duplicate. *Open markers indicate P<0.005 vs 
 
539 
 
540 
non-infected controls. 
 
541  Figure 2: CD14 contributes to control of UPEC. WT and CD14-deficient mice were 
 
542  infected with UPEC and euthanised 21-24 h p.i. Bladders (A), urine (B) and kidneys 
 
543  (C)  were  collected  and  colony  counts  were  performed.  Data  are  displayed  with 
 
544  median bars (n=15 tissues, n=20-23 urines) and are representative of three separate 
 
545  experiments. The Mann Whitney U-test was used to test for significant differences. In 
 
546  separate time course experiments in mice (D) the number of UPEC cultured from urine 
 
547  collected from CD14-deficient mice was significantly higher compared to WT mice at 
 
548  24-48  h  p.i.,  however,  the  differences  at  8  and  120  h  p.i.  were  not  statistically 
 
549 
 
550 
significant. 
 
551  Figure 3: Summary of CD14-dependent and independent UPEC-induced gene 
 
552  expression. (A) Number of genes significantly up- and down-regulated in infected 
553  WT mice vs WT mice that received PBS (left), and infected Cd14-/-  mice vs Cd14-/- 
 
554  mice that received PBS (right). (B) Number of genes significantly up- and down- 
 
555  regulated in infected WT mice vs infected Cd14-/-  mice (left), and in WT mice that 
 
556  received PBS vs Cd14-/- mice that received PBS (right). There are 50 genes shared 
 
557  among the lists of 513 and 407 genes in (B) defining a unique UPEC-induced CD14- 
 
558  dependent transcriptional signature of 491 genes. (C) Major functional groupings of 
 
559  genes  that  define  the  UPEC-induced  CD14-dependent  transcriptional  signature 
 
560  according to IPA-predicted canonical pathways, biological functions, and upstream 
 
561 
 
562 
mediators and over-represented pathways according to InnateDB ORA (top 6 shown). 
 
 
563  Figure 4: Influx and depletion of F4/80+ and CD14+ cells in bladder of mice with 
 
564  UPEC UTI. Mice were infected and bladders were collected and analysed using flow 
 
565  cytometry at 2 h, 24 h and 5 d p.i. Cells were stained with anti-F4/80 and anti-CD14 to 
 
566  determine the influx of  these cells into the bladder (A). Mice were injected with 
 
567  liposomes  containing  PBS  (controls)  or  clodronate  at  24  h  and  2  h  prior  to 
 
 
568  transurethral infection with UPEC to deplete F4/80+  and CD14+  cells. Bladders and 
 
569  spleens were collected, processed and stained with an anti-F4/80-APC antibody to 
 
570  determine the effect of liposome treatments (B). Data are mean ± SE of 10 bladders 
 
571  and represent two separate experiments. Bladders from mice infected transurethrally 
 
572  with cherry red-expressing UPEC were processed to visualize F4/80 (C; green) and 
 
573  CD14 (D; green) following liposome treatments. Arrows: F4/80, CD14, or cherry red 
 
574  fluorescent UPEC shown at 5  d; Scale bars = 20 µm. Two-way ANOVA and a 
 
575  Bonferroni’s post-test was used for statistical analysis, with significance set at P<0.05. 
 
576 
 
577 
PL: PBS Liposomes; CL: Clodronate Liposomes. *: P<0.0001; †: P<0.01; #: P<0.05. 
578  Figure 5: The effect of clodronate treatment on UPEC UTI in vivo. Mice were 
 
579  administered liposomes containing PBS (PL) or Clodronate (CL) at 24 h and 2 h prior 
 
580  to infection with UPEC, and bacteria were enumerated in bladders and urines at 2 h 
 
581  (A, D), 24 h (B, E) and 5 d p.i. (C, F). Data bars indicate medians (n=12-25) and 
 
582  represent two separate experiments. Mann-Whitney U-tests were used to compare 
 
583 
 
584 
groups with significance set at P<0.05. 
 
585  Supplementary Figure S1:  Top four IPA-defined networks of over-expressed 
 
586  genes  in  UPEC-induced  CD14-dependent  responses  in  the  bladder.  The 
 
587  pathways are: (A) Endocrine system disorder, gastrointestinal disease, immunological 
 
588  disease; (B) Embryonic development, organ development, organ morphology; (C) 
 
589  Cell-to-cell signalling and interaction, cellular growth and proliferation, nervous system 
 
590  development  and  function;  (D)  Hematological  system  development  and  function, 
 
591  immune cell trafficking, inflammatory response. For networks, the node (gene) and 
 
592  edge (gene relationship) symbols are described below; node color intensity indicates 
 
593  the degree of up-regulation (red) or down-regulation (green). Genes in uncolored 
 
594  nodes were not identified as differentially expressed and were integrated into the 
 
595  networks using evidence stored in IPA indicating a relevance to this network. The 
 
596  node shapes denote enzymes (  ), phosphatases (  ), kinases ( ), peptidases ( ), G- 
 
597  protein coupled receptor (  ), transmembrane receptor (  ), cytokines (  ), growth factor 
 
598  ( ), ion channel ( ), transporter ( ), translation factor ( ), nuclear receptor ( ), 
 
599 
 
600 
transcription factor ( ) and other ( ). 
 
601  Supplementary Table S1: Role of CD14 in UPEC-regulated host transcriptional 
 
602  responses in the bladder including gene networks triggered by UTI. The lists 
603  represent (A) WT mice in infection and control conditions; (B) CD14-deficient mice in 
 
604  infection and control conditions; (C) WT mice vs CD14-deficient mice in infected and 
 
605  PBS  control  groups  used  to  define  a  unique  UPEC-regulated,  CD14-dependent 
 
606  transcriptional signature of 491 genes in (D). Highly activate canonical pathways that 
 
607  are induced via CD14-dependent mechanisms in UPEC-infected WT mice compared 
 
608  to UPEC-infected CD14-deficient mice, as identified by IPA (E); Gene Set Enrichment 
 
609  Analysis (GSEA; www.broadinstitute.org/gsea/), used to compare IPA-derived results, 
 
610  identified many of the same active pathways (data not shown). InnateDB ORA pathway 
 
611  data, ranked according to P value, are listed in (F). Red and Green indicates up- and 
 
612  down-regulated, respectively; top 50 hits are colored to highlight consistency in ORA 
 
613  results using subset RNA-seq data (n=491 genes) vs whole RNA-seq dataset; white 
 
614  indicates P>0.05 using whole RNA-seq dataset. N.C.A., not currently annotated. The 
 
615  translational responses of WT mice in infection and control conditions, and CD14- 
 
616  deficient mice in infection conditions (normalized to equivalent CFU in WT mice to 
 
617  enable comparison), measured using multiplex protein assay essentially as described 
 
618  elsewhere [11] (n=10 per group), are provided in (G). 
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